Skip to main content
SpringerLink
Log in

Establishment of the model of vascular endothelial cell membrane chromatography and its preliminary application

  • Articles
  • Published:
Chinese Science Bulletin

Abstract

A model of vascular endothelial cell membrane chromatography was established by using an ECV304 cell membrane stationary phase (ECV304 CMSP) prepared by immobilizing the ECV304 cell membrane onto the surface of silica carrier. The surface and chromatographic characteristics of ECV304 CMSP were studied. The active component from Caulophyllum robustum was screened by using the model of vascular endothelial cell membrane chromatography. The interaction between the active component and membrane receptor was determined by using a replace experiments. The effect of the active component was tested by using tube formation of ECV304 cell. The results indicated that the model of ECV304 cell membrane chromatograph (ECV304 CMC) can stimulate the interaction between drug and receptor in vitro and the retention characteristics of taspine as active component was similar to that of model molecule in the model of ECV304 CMC. And therefore, taspine acted on VEGFR2 and inhibited the tube formation of ECV304 cell induced by VEGF. This model can be used to screen definite active component as a screening model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. He L C, Geng X D. Cell membrane chromatography-new method of the interactions between drug and receptor. New Progr Biomed Chromatogr, 1996, 3: 8–9

    Google Scholar 

  2. He L C, Yang G D, Geng X D. Enzymatic activity and chromatographic characteristics of the cell membrane immobilized on silica surface. Chin Sci Bull, 1999, 44(9): 826–831

    Article  Google Scholar 

  3. He L C, Wang S C, Geng X D. Coating and fusing cell membrane onto a silica surface and their chromatographic characteristics. Chromatographia, 2001, 54: 71–76

    Article  Google Scholar 

  4. Zhang D, Yuan B X, Deng X L, et al. Chromatography studies on bio-affinity of nine ligands of α1-adrenoceptor to α1D subtypes over-expressed in cell membrane. Sci China Ser C-Life Sci, 2004, 47(4): 376–381

    Article  Google Scholar 

  5. Hou J, Yuan B X, He L C, et al. Evaluation of drug-muscarinic receptor affinities by using cell membrane chromatography. Chin J Pharmacol Toxicol, 2003, 17: 70–73

    Google Scholar 

  6. Wang Y, Yuan B X, Deng X L, et al. The preparation of HEK293 1A or 1B cell membrane stationary phase and the chromatography affinity study of ligands of α1-adrenoceptor. Anal Biochem, 2005, 339: 198–205

    Article  Google Scholar 

  7. Yuan B X, Hou J, He L C, et al. Evaluation of drug-muscarinic receptor affinities using cell membrane chromatography and radioligand binding assay in guinea pig jejunum membrane. Acta Pharmacol Sin, 2005, 26: 113–116

    Article  Google Scholar 

  8. Liang M J, He L C, Yang G D. Screening, analysis and in vitro vasodilatation of effective components from Ligusticum Chuanxiong. Life Sci, 2005, 78: 128–133

    Article  Google Scholar 

  9. Carmeliet P, Jain R K. Angiogenesis in cancer and other diseases. Nature, 2000, 407: 249–257

    Article  Google Scholar 

  10. Folkman J. Angiogenesis and apoptosis. Semin Cancer Biol, 2003, 13: 159–167

    Article  Google Scholar 

  11. Arbiser J L. Regulation of angiogenesis and tumorigenesis. Semin Cancer Biol, 2004, 14: 79–80

    Article  Google Scholar 

  12. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med, 1995, 1: 27–31

    Article  Google Scholar 

  13. Sandra L, Erik D C, Johan N. Angiogenesis: Regulators and clinical applications. Biochem Phar, 2001, 61: 253–262

    Article  Google Scholar 

  14. Ziegler B L, Valtieri M, Porada G A, et al. KDR receptor: A key marker defining haemopoietic stem cells. Science, 1999, 285: 1553–1558

    Article  Google Scholar 

  15. Veikkola T, Karkkainen M, Claesson-Welsh L, et al. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res, 2000, 60: 203–212

    Google Scholar 

  16. Prewett M, Huber J, Li Y, et al. Antivascular endothelial growth factor receptor monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res, 1999, 59: 5207–5218

    Google Scholar 

  17. Miura S, Emoto M, Matsuo Y, et al. Carcinosarcoma-induced endothelial cells tube formation through KDR/Flk-1 is blocked by TNP-470. Cancer Letts, 2004, 203: 45–50

    Article  Google Scholar 

  18. Haspel H C, Sciclli G M, Mcmahom G, et al. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Microvascular Res, 2002, 63: 304–315

    Article  Google Scholar 

  19. Shim D H, Hee Y K. Protein kinase B inhibits apoptosis induced by actinomycin D in ECV304 cells through phosphorylation of caspase 8. Arch Biochem Biophys, 2004, 21: 214–220

    Article  Google Scholar 

  20. Liang G B, Zhang G P, Jin H M. Influence of basic fibroblast growth factor on ECV304 cell migration. Chin J Pathophysiol, 2005, 21: 16–20

    Google Scholar 

  21. Zhang J T. Modern Experimental Methods in Pharmacology (in Chinese). Beijing: Beijing Medical University and Beijing Xiehe Medical University Unite Press, 1998. 999–1015

    Google Scholar 

  22. Lowry O H, Rosebrough N J, Farr A L, et al. Protein measurement with the Folin phenol reagent. J Bio Chem, 1951, 193: 265–276

    Google Scholar 

  23. Li Y P, He L C. Inhibitory effects of the alkaloids from Radix Caulophylli on the proliferation of human vascular endothelial cell. Acad J Xi’an Jiao Tong Univ, 2005, 17: 185–187

    Google Scholar 

  24. Perdue G P, Blomster R N, Blake D A, et al. South american plants II. Taspine isolation and anti-inflammatory activity. J Pham Sci, 1979, 6: 124–127

    Article  Google Scholar 

  25. Itokawa H, Ichihara Y. A cytotoxic substance from Sangre de Grado. Chem Pharm Bull (Tokyo), 1991, 39: 1041–1042

    Google Scholar 

  26. Bertucci C, Bartolini M, Gotti R, et al. Drug affinity to immobilized target bio-polymers by high-performance liquid chromatography and capillary electrophoresis. J Chromatogr B, 2003, 797: 111–129

    Article  Google Scholar 

  27. Tong Y G, Zhang X W, Zhao W M, et al. Anti-angiogenic effects of Shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis. Euro J Pharm, 2004, 494: 101–109

    Article  Google Scholar 

  28. Prewett M, Huber J, Li Y, et al. Antivascular endothelial growth factor receptor (flk-1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res, 1999, 59: 5209–5218

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, School of Medicine, Xi’an Jiaotong University, Xi’an, 710061, China

    Li YiPing & He LangChong

Authors
  1. Li YiPing
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. He LangChong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to He LangChong.

About this article

Cite this article

Li, Y., He, L. Establishment of the model of vascular endothelial cell membrane chromatography and its preliminary application. CHINESE SCI BULL 52, 922–928 (2007). https://doi.org/10.1007/s11434-007-0149-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11434-007-0149-5

Keywords

Search

Navigation